Source: International Congress 2017 – Clinical impact of nontuberculous mycobacterial (NTM) disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Jakko van Ingen (Nijmegen, Netherlands). Microbiological diagnosis of NTM pulmonary disease. International Congress 2017 – Clinical impact of nontuberculous mycobacterial (NTM) disease

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018 Radiological features of NTM pulmonary disease in patients with bronchiectasis Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease Source: Eur Respir J 2016; 48: 928-931 Year: 2016 Surgery in nontuberculous mycobacteria pulmonary disease Source: Breathe, 14 (4) 288; 10.1183/20734735.027218 Year: 2018 Pulmonary tuberculosis without bacteriological confirmation – a diagnosis problem Source: Eur Respir J 2006; 28: Suppl. 50, 14s Year: 2006 Non-tuberculous mycobacterial pulmonary disease Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019 Year: 2019 When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017 Cure rates in nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Immunological criterions of the pulmonary tuberculosis progression Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Pulmonary nontuberculous mycobacerial disease in elderly patients Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Year: 2020 New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Source: Virtual Congress 2020 – German programme 2020 Year: 2020 Non tuberculous mycobacterial pulmonary disease in the elderly Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Early diagnosis of extrapulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 543s Year: 2006